Physician profile
Tankut Onal
NPI 1285710855
$319.43
in general payments reported to CMS, 2019-2025
11 companies · $20.57 in 2025
The $20.57 reported for 2025 was less than what a typical Pediatric Cardiology provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $121 · 2020: $56.21 · 2021: $62.00 · 2022: $59.72 · 2025: $20.57.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $20.57.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $20.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $101.11 | 2019 | |
| Abbott Laboratories | $39.13 | 2022 | |
| Ucb, INC. | $24.71 | 2020 | |
| Zogenix INC. | $24.13 | 2021 | |
| Boston Scientific Corporation | $20.59 | 2022 | |
| Soleno Therapeutics, INC. | $20.57 | 2025 | Vykat Xr |
| Novo Nordisk INC | $19.99 | 2021 | |
| Jazz Pharmaceuticals INC. | $19.82 | 2019 | |
| Sobi, INC | $17.88 | 2021 | |
| Csl Behring | $17.11 | 2020 | |
| Neurelis, INC. | $14.39 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tankut Onal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.